Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer

被引:4
|
作者
Kumano, Koichiro [1 ]
Nakahashi, Hiromitsu [1 ]
Louphrasitthiphol, Pakavarin [1 ,2 ]
Kuroda, Yukihito [1 ]
Miyazaki, Yoshihiro [1 ]
Shimomura, Osamu [1 ]
Hashimoto, Shinji [1 ]
Akashi, Yoshimasa [1 ]
Mathis, Bryan J. [3 ]
Kim, Jaejeong [1 ]
Owada, Yohei [1 ]
Goding, Colin R. [2 ]
Oda, Tatsuya [1 ]
机构
[1] Univ Tsukuba, Fac Med, Dept Gastrointestinal & Hepatobiliary Pancreat Sur, Tsukuba, Japan
[2] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Med, Oxford, England
[3] Univ Tsukuba Hosp, Int Med Ctr, Tsukuba, Japan
基金
日本学术振兴会;
关键词
3D organoid; pancreatic cancer; hypoxia; tumor heterogeneity; selection bias; TUMOR; EXPRESSION; INDUCTION; CELLS;
D O I
10.3389/fcell.2024.1327772
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Pancreatic ductal adenocarcinoma (PDAC) is especially hypoxic and composed of heterogeneous cell populations containing hypoxia-adapted cells. Hypoxia as a microenvironment of PDAC is known to cause epithelial-mesenchymal transition (EMT) and resistance to therapy. Therefore, cells adapted to hypoxia possess malignant traits that should be targeted for therapy. However, current 3D organoid culture systems are usually cultured under normoxia, losing hypoxia-adapted cells due to selectivity bias at the time of organoid establishment. To overcome any potential selection bias, we focused on oxygen concentration during the establishment of 3D organoids. We subjected identical PDAC surgical samples to normoxia (O2 20%) or hypoxia (O2 1%), yielding glandular and solid organoid morphology, respectively. Pancreatic cancer organoids established under hypoxia displayed higher expression of EMT-related proteins, a Moffitt basal-like subtype transcriptome, and higher 5-FU resistance in contrast to organoids established under normoxia. We suggest that hypoxia during organoid establishment efficiently selects for hypoxia-adapted cells possibly responsible for PDAC malignant traits, facilitating a fundamental source for elucidating and developing new treatment strategies against PDAC.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Cellos: High-throughput deconvolution of 3D organoid dynamics at cellular resolution for cancer pharmacology
    Mukashyaka, Patience
    Kumar, Pooja
    Mellert, Dave
    Nicholas, Shadae
    Noorbakhsh, Javad
    Brugiolo, Mattia
    Anczukow, Olga
    Liu, Edison T.
    Chuang, Jeffrey H.
    CANCER RESEARCH, 2023, 83 (07)
  • [42] High-throughput deconvolution of 3D organoid dynamics at cellular resolution for cancer pharmacology with Cellos
    Mukashyaka, Patience
    Kumar, Pooja
    Mellert, David J.
    Nicholas, Shadae
    Noorbakhsh, Javad
    Brugiolo, Mattia
    Courtois, Elise T.
    Anczukow, Olga
    Liu, Edison T.
    Chuang, Jeffrey H.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [43] Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing
    Van Hemelryk, Annelies
    Mout, Lisanne
    Erkens-Schulze, Sigrun
    French, Pim J.
    van Weerden, Wytske M.
    van Royen, Martin E.
    BIOMOLECULES, 2021, 11 (11)
  • [44] A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer
    Sabra I. Djomehri
    Boris Burman
    Maria E. Gonzalez
    Shuichi Takayama
    Celina G. Kleer
    Journal of Cell Communication and Signaling, 2019, 13 : 129 - 143
  • [45] A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer
    Djomehri, Sabra I.
    Burman, Boris
    Gonzalez, Maria E.
    Takayama, Shuichi
    Kleer, Celina G.
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2019, 13 (01) : 129 - 143
  • [46] Cellos: High-throughput deconvolution of 3D organoid dynamics at cellular resolution for cancer pharmacology
    Mukashyaka, Patience
    Kumar, Pooja
    Mellert, David J.
    Nicholas, Shadae
    Noorbakhsh, Javad
    Brugiolo, Mattia
    Anczukow, Olga
    Liu, Edison T.
    Chuang, Jeffrey H.
    CANCER RESEARCH, 2024, 84 (03)
  • [47] Anti-cancer effects of vorinostat on 3D cultured pancreatic cancer cells
    Emamzaden, Fatemeh Nouri
    Word, Beverly
    Hammons, George
    Lyn-Cook, Beverly D.
    CANCER RESEARCH, 2022, 82 (12)
  • [48] U-Shape Pillar Strip for 3D Cell-Lumped Organoid Model (3D-COM) Mimicking Lung Cancer Hypoxia Conditions in High-Throughput Screening (HTS)
    Lee, Sang-Yun
    Lee, Eunyoung
    Lim, Jeong Uk
    Ku, Bosung
    Seong, Yu-Jeong
    Ryu, Ji-O
    Cho, Hyeong Jun
    Kim, Kyuhwan
    Hwang, Yongki
    Moon, Seok Whan
    Moon, Mi Hyoung
    Kim, Kyung Soo
    Hyun, Kwanyong
    Kim, Tae-Jung
    Sung, Yeoun Eun
    Choi, Joon Young
    Park, Chan Kwon
    Kim, Sung Won
    Yeo, Chang Dong
    Kim, Seung Joon
    Lee, Dong Woo
    ANALYTICAL CHEMISTRY, 2024, 96 (25) : 10246 - 10255
  • [49] Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening
    Rao, Xinxin
    Qiao, Zhibin
    Yang, Yang
    Deng, Yun
    Zhang, Zhen
    Yu, Xiaoli
    Guo, Xiaomao
    PHARMACEUTICALS, 2024, 17 (02)
  • [50] Differences of statin activity in 2D and 3D pancreatic cancer cell cultures
    Paskeviciute, Migle
    Petrikaite, Vilma
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 3273 - 3280